Form 4: Enliven Therapeutics CFO Benjamin Hohl Executes Option Exercise and Stock Sale
SEC Form 4 Filing
Benjamin Hohl, CFO of Enliven Therapeutics, exercised stock options and sold shares under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On July 12, 2024, Benjamin Hohl, the CFO of Enliven Therapeutics, exercised options to purchase 3,000 shares of common stock at a price of $2.48 per share.
- Simultaneously, Hohl sold 3,000 shares of common stock at a weighted average price of $25.065, with individual sales ranging from $25.00 to $25.19.
- These transactions were executed under a Rule 10b5-1 trading plan adopted on June 26, 2023.
- Following these transactions, Hohl directly owns 0 shares of common stock and 209,620 stock options.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reports routine transactions under a pre-arranged trading plan. There is no indication of positive or negative implications for the company.
Industry Context
Form 4 filings are standard practice and provide transparency into the trading activities of company insiders. The use of a 10b5-1 trading plan suggests that these trades were pre-planned and not based on any inside information at the time of the transactions.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the use of a 10b5-1 plan mitigates concerns about insider trading.
Key Dates
| Date | Description |
|---|---|
| June 26, 2023 | Date the Reporting Person adopted the Rule 10b5-1 trading plan |
| August 2, 2022 | Date when one-fourth of the option shares vested. |
| July 12, 2024 | Date of the option exercise and stock sale. |
| August 2, 2031 | Expiration date of the stock options. |
| Ongoing | Remainder of the shares vest in 36 equal monthly installments after August 2, 2022. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.